Our Pulmonary Development and Disease Pathogenesis Training Program aims to provide advanced research training by supporting stipends for three pre-doctoral and for five post-doctoral candidates within the University of Cincinnati College of Medicine (UCCOM) and Cincinnati Children?s Hospital Medical Center (CCHMC) graduate and post-graduate training programs. The training environment draws upon established, integrated, innovative graduate and postgraduate programs focused to molecular, developmental, and cell biology and outstanding clinical, translational programs focused to pediatric and adult pulmonary diseases and radiological imaging research. The T32 program benefits from strong NHLBI-supported research programs and brings together more than 36 distinguished, NIH-funded investigators experienced in modern molecular and cell biology, physiology and imaging strategies to study lung development and diseases. Program faculty have shared research interests and active collaborations in basic and translational research. Major research themes include pathogenesis of pulmonary disorders and will also focus to the pulmonary vasculature. Gene expression among cells, function, and regulation during organ development, injury, and repair are areas of interest. Likewise, development of biomarkers, imaging, and therapeutics for lung and pulmonary vascular diseases are areas of excellence. Promising trainees engaged in pre- or post-doctoral training programs are identified and selected on a competitive basis. PhD and MD/PhD predoctoral trainees obtain their PhD degrees in Graduate Programs in Developmental Biology, Immunobiology, Biomedical Informatics, Pathobiology and Molecular Medicine or Molecular Genetics (Biochemistry-Microbiology) at the University of Cincinnati College of Medicine. Post- doctoral trainees may have an MD or PhD degree, or both, and are recruited to our T32 Mentor laboratories. Special attention is given to recruitment of minority individuals and physician scientist candidates seeking their PhD/MD degree. Research training includes mentoring in career development, training in the responsible conduct of research, reproducibility and scientific rigor, ethics in research, research presentation skills and various seminars and courses within the graduate and divisional programs in which the trainees and their training faculty participate. Trainees attend regular research meetings and pertinent seminar series. Program Administration includes the contact Co-PI and three Co-Principal Investigators, who form the Executive Committee, and both External and Internal Advisory Committees. The progress of each trainee, quality of mentors, and overall effectiveness of the program is critically reviewed annually. Trainees will meet with their Mentor regularly, the T32 Program Director and Co-Directors quarterly, and their Mentoring Committee at least biannually. This T32 renewal application (Years 25-30) will permit us to continue a program with outstanding productivity in preparing new investigators to enhance research training and competence in critical aspects of pulmonary and cardiovascular development and disease pathogenesis.
This renewal T32 grant application for a Pulmonary Development and Disease Pathogenesis Training Program seeks to continue support to recruit and train outstanding pre-doctoral and post-doctoral candidates, preparing them to advance science and make discoveries that improve the diagnosis and treatment of pulmonary diseases, enabling them to become future research leaders in research and medicine. This Program meets a critical national need to increase the quantity and quality of young investigators who can apply cellular, molecular, and genetic strategies to the study of lung disorders. There is an ever-increasing loss of M.D. and Ph.D. candidates from academic-scientific careers at a time in which unparalleled opportunities exist to identify mechanisms of underlying disease pathogenesis and to develop novel biomarkers, diagnostics, and treatment strategies to improve human health.
|Higano, Nara S; Spielberg, David R; Fleck, Robert J et al. (2018) Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short-Term Clinical Outcomes. Am J Respir Crit Care Med 198:1302-1311|
|Gokey, Jason J; Sridharan, Anusha; Xu, Yan et al. (2018) Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. JCI Insight 3:|
|Maliken, Bryan D; Molkentin, Jeffery D (2018) Undeniable Evidence That the Adult Mammalian Heart Lacks an Endogenous Regenerative Stem Cell. Circulation 138:806-808|
|Bueter, Chelsea L; Deepe Jr, George S (2018) Aeroallergens Exacerbate Histoplasma capsulatum Infection. J Immunol 201:3352-3361|
|Gokey, Jason J; Snowball, John; Sridharan, Anusha et al. (2018) MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation. JCI Insight 3:|
|Hahn, Andrew D; Higano, Nara S; Walkup, Laura L et al. (2017) Pulmonary MRI of neonates in the intensive care unit using 3D ultrashort echo time and a small footprint MRI system. J Magn Reson Imaging 45:463-471|
|Thomen, Robert P; Walkup, Laura L; Roach, David J et al. (2017) Hyperpolarized129Xe for investigation of mild cystic fibrosis lung disease in pediatric patients. J Cyst Fibros 16:275-282|
|Noel, John G; Ramser, Benjamin J; Cancelas, Jose A et al. (2017) Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice. Exp Hematol 56:16-30|
|Schwanekamp, Jennifer A; Lorts, Angela; Sargent, Michelle A et al. (2017) TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. PLoS One 12:e0181945|
|Stevens, Mariana L; Chaturvedi, Praneet; Rankin, Scott A et al. (2017) Genomic integration of Wnt/?-catenin and BMP/Smad1 signaling coordinates foregut and hindgut transcriptional programs. Development 144:1283-1295|
Showing the most recent 10 out of 63 publications